Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

9 terminated/withdrawn out of 160 trials

Success Rate

90.5%

+4.0% vs industry average

Late-Stage Pipeline

15%

24 trials in Phase 3/4

Results Transparency

13%

11 of 86 completed trials have results

Key Signals

19 recruiting11 with results7 terminated

Enrollment Performance

Analytics

N/A

59(54.1%)

Phase 2

19(17.4%)

Phase 4

17(15.6%)

Phase 3

7(6.4%)

Phase 1

6(5.5%)

Early Phase 1

1(0.9%)

109Total

N/A(59)

Phase 2(19)

Phase 4(17)

Phase 3(7)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (160)

Showing 20 of 160 trials

NCT05665127Active Not Recruiting

Point of Care Evaluation of High-sensitivity Cardiac Troponin

Role: collaborator

NCT05434195Not ApplicableRecruiting

Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive Pregnancies

Role: collaborator

NCT03952351Not ApplicableActive Not Recruiting

Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography

Role: collaborator

NCT03843255Active Not Recruiting

Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy

Role: collaborator

NCT05198791Phase 2Recruiting

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

Role: collaborator

NCT05568069Not ApplicableRecruiting

RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

Role: collaborator

NCT03252249Phase 4Completed

Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

Role: collaborator

NCT06478277Recruiting

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

Role: collaborator

NCT03920176Not ApplicableActive Not Recruiting

Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (The SCOT-HEART 2 Trial)

Role: collaborator

NCT04319627Phase 3Recruiting

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Role: collaborator

NCT05636748Recruiting

The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke

Role: collaborator

NCT05815745Not ApplicableRecruiting

"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)

Role: collaborator

NCT04156061Not ApplicableActive Not Recruiting

Effect of the SCOT-HEART 2 Trial on Lifestyle.

Role: collaborator

NCT05410873Phase 2Completed

Examining the Effects of Mitochondrial Oxidative Stress in DCM

Role: collaborator

NCT05898165Active Not Recruiting

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study

Role: collaborator

NCT06061822Not ApplicableRecruiting

Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation

Role: collaborator

NCT05776212Recruiting

Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Role: collaborator

NCT05622500Not ApplicableTerminated

Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease

Role: collaborator

NCT06951100Recruiting

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Role: collaborator

NCT00135226Phase 4Active Not Recruiting

ASCEND: A Study of Cardiovascular Events iN Diabetes

Role: collaborator